Health

Sterile Lancets Market Clinical Review, Drug Descriptions, Analysis And Synthesis 2018-2026

Press Release

Coherent Market Insights added Latest Research Report titled ” Sterile Lancets Market, by Product Type (Conventional Sterile Lancets and Safety Sterile Lancet), by Application (Diabetes and Others), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and by Geography – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026 ” to its Large Report database.

Sterile lancets are single-use disposable needles that are used for blood sampling by puncturing the skin. Sterile lancets can be used independently as safety lancet or they can be used along with the lancing device, which holds the lancet while pricking the skin. Skin testing for allergies can also be performed with the help of sterile lancets.

Sterile Lancets Market – Dynamics

Increasing prevalence of diabetes is one of the major factors driving growth of the sterile lancet market. For instance, according to the International Diabetes Federation’s (IDF) Diabetes Atlas 2017, around 425 million patients were suffering from diabetes worldwide by end of 2017 and it is expected to reach around 629 million by 2045. Moreover, over 40% people suffering from diabetes are still undiagnosed, especially in regions such as Asia Pacific, Middle East and some part of North Africa. These patients would require insulin therapy, which would increase the demand for sterile lancets and fuel growth of the sterile lancets market.

According to the World Health Organization (WHO) 2012 factsheet, diabetes is one of the top three causes of death from non-communicable diseases. Changes in lifestyle with more sedentary routine and high calorie consumption leads to obesity. Increasing geriatric population is another factor driving the sterile lancet market growth, as older people often require continuous glucose monitoring due to large incidences of uncontrolled diabetes. As per 2017 IDF estimation, there were around 98 million diabetic people worldwide above the age of 65 years in 2017, which is expected to increase to around 191 million by 2045.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1994

Sterile Lancets Market – Competitive Landscape

Some of the key players operating in the sterile lancet market include Becton, Dickinson and Company, F-Hoffmann La Roche AG, Nipro Corporation, Ypsomed AG, Sanofi, Abbott Healthcare, B. Braun Melsungen AG, Sarstedt AG & Co., Terumo Corporation, Medtronic plc., Greiner Bio One, Jiangsu Huida Medical Instruments Co. Ltd., Allison Medical, Inc., and A. Menarini Diagnostics

Sterile Lancets Market – Regional Insights

North America holds the dominant position in the global sterile lancets market. According to the International Diabetes Federation (IDF), highest prevalence of diabetes (13% of population) is in the U.S. North America accounts for the highest amount of expenditure on diabetes. For instance, according to IDF report 2017, the U.S. spends around US$ 377 billion annually over diabetes disease treatment, which accounts for around 52% of the total expenditure on diabetes worldwide.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.